Navigation Links
Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ

Sunnyvale, CA. (PRWEB) April 09, 2013

The sixth session of the Silicon Valley BioTalks tackles the debate “Is EDC becoming a commodity?” The event takes place on April 17 at Onyx Pharmaceuticals headquarters in South San Francisco from 5.30pm – 8.00pm PDT and includes expert panelists from Onyx Pharmaceuticals, Clinical Leader, Clinovo and MedStars. The panel discussion will be simultaneously streamed online.

Described as “a truly informative panel discussion” and “a great forum to hear very experienced clinical trial professionals,” the Silicon Valley BioTalks is the venue for clinical trial professionals looking to stay ahead of trends and technologies in the life science industry. Over 60 healthcare industry professionals attended the most recent sessions, on CDISC standards, systems integration, and FDA regulations.

Wednesday, April 17 - 5.30pm – 8.00pm PDT

The event is free of charge with registration before April 12, 2013:

Hosted at Onyx Pharmaceuticals.

The panel is composed of EDC experts Eric Morrie, Manager of Clinical Programming at Onyx Pharmaceuticals, Dr. Omar Dawood of Clinical Leader, Marc Desgrousilliers, CTO at Clinovo and Dr. Bob Molinari, CEO of Retrotype & Partner at MedStars. They will share insights on the evolution of the EDC market over the last 10 years, key players and influencers in the field, best practices for a successful implementation, and how EDC is evolving in today’s marketplace.

With clinical research one of the most expensive areas of drug development, Electronic Data Capture (EDC) has become an increasingly popular solution to lowering costs. Studies suggest that using EDC systems drastically reduces data errors and speeds up the overall trial process, reducing clinical research costs by up to 20%.
Despite the benefits, adoption of EDC systems has remained slow. By December 2012, only 40% of Phase I clinical trials utilized EDC. How can these low adoption rates be explained? Do the currently-available EDC systems effectively meet sponsor companies’ needs?

Event details:
Wednesday, April 17, 2013
5.30pm – 8.00pm PDT

Onyx Pharmaceuticals
249 East Grand Avenue
South San Francisco, California 94080

Register for free before April 12, 2013:

Click here to read panelists' bios

  •     Eric Morrie, Manager, Clinical Programming at Onyx Pharmaceuticals
  •     Dr. Omar Dawood, M.D., M.P.H., Visionary Senior Executive and Clinical Leader
  •     Marc Desgrousilliers, Chief Technology Officer at Clinovo
  •     Moderated by Dr. Bob Molinari, Ph.D., C.E.O. at Retrotope & Partner at MedStars

About the Silicon Valley BioTalks
The Silicon Valley BioTalks is a quarterly series of free panel discussions, sponsored by Clinovo, for life science professionals looking to streamline their clinical trials. Representatives from leading pharmaceutical, biotechnology, and medical device companies share expertise and best practices about hot topics in the industry.
Read about the latest sessions on

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Building quantum states with individual silicon atoms
3. New material interface improves functioning of non-silicon-based electronic devices
4. New world record efficiency for thin film silicon solar cells
5. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
6. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
7. Tiny compound semiconductor transistor could challenge silicons dominance
8. Flexible silicon solar-cell fabrics may soon become possible
9. Fabrication on patterned silicon carbide produces bandgap to advance graphene electronics
10. Rice team boosts silicon-based batteries
11. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
Post Your Comments:
(Date:6/27/2016)... 2016  Sequenom, Inc. (NASDAQ: SQNM ), ... through the development of innovative products and services, announced ... United States denied its petition to review ... Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") are not ... the Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories ...
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
Breaking Biology Technology:
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( ) will also ... by the use of DNA technology to an industry ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):